J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Caterina, R.
Right arrow Articles by Libby, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Caterina, R.
Right arrow Articles by Libby, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Journal of Lipid Research, Vol. 39, 1062-1070, May 1998
Copyright © 1998 by Lipid Research, Inc.


Original Article

Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids

Raffaele De Caterinaa, Walter Berninia, Maria Annunziata Carlucciob, James K. Liaoc, and Peter Libbyc
a C.N.R. Institute of Clinical Physiology, Pisa, Italy
b C.N.R. Institute of Clinical Physiology, Lecce, Italy
c Women's Hospital, Boston, MA 02115

Correspondence to: Raffaele De Caterina.

Dietary long-chain fatty acids (FA) may influence pathological processes involving endothelial activation, including inflammation and atherosclerosis. We have previously shown that the n–3 FA docosahexaenoate (DHA) inhibits endothelial activation in the range of nutritionally achievable plasma concentrations. The present study assessed structural determinants for this effect. Saturated, monounsaturated, and n–6 and n–3 polyunsaturated FA were incubated with cultured endothelial cells for 24–72 h alone, and then in the presence of interleukin-1, tumor necrosis factor, or bacterial lipopolysaccharide for an additional 24 h before assessing the expression of the vascular cell adhesion molecule-1 (VCAM-1) or other products of endothelial activation. No FA tested per se elicited endothelial activation. While saturated FA did not inhibit cytokine-induced expression of adhesion molecules, a progressively increasing inhibitory activity was observed, for the same chain length, with an increase in double bonds. Comparison of FA with the same length and number of unsaturation and only differing for the double bond position or for the cis/trans configuration indicated no difference in inhibitory potency, indicating no effect of the double bond position or configuration. As judged by Northern analysis, these latter FA also inhibited VCAM-1 messenger RNA steady state levels to the same extent, indicating a pre-translational site of action attributable to the single double bond. Thus the double bond is the minimum necessary and sufficient requirement for FA inhibition of endothelial activation. These properties are likely relevant to the anti-atherogenic and anti-inflammatory properties ascribed to n–3 FA, which are able to accommodate the highest number of double bonds in a fatty acid of given chain length.—De Caterina, R., W. Bernini, M. A. Carluccio, J. K. Liao, and P. Libby. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J. Lipid Res. 1998. 39: 1062–1070.

Supplementary key words: leukocyte adhesion molecules, VCAM-1, E-selectin, cytokines, n–3 fatty acids, omega–3 fatty acids, double bonds, atherosclerosis, inflammation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
R. De Caterina, R. Madonna, A. Bertolotto, and E. B. Schmidt
n-3 Fatty Acids in the Treatment of Diabetic Patients: Biological rationale and clinical data
Diabetes Care, April 1, 2007; 30(4): 1012 - 1026.
[Full Text] [PDF]


Home page
IOVSHome page
W. Chen, D. B. Jump, W. J. Esselman, and J. V. Busik
Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Modification of Caveolae/Lipid Rafts by Docosahexaenoic Acid
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 18 - 26.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Massaro, A. Habib, L. Lubrano, S. D. Turco, G. Lazzerini, T. Bourcier, B. B. Weksler, and R. De Caterina
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{varepsilon} inhibition
PNAS, October 10, 2006; 103(41): 15184 - 15189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Niu, A. Hozawa, S. Kuriyama, K. Ohmori-Matsuda, T. Shimazu, N. Nakaya, K. Fujita, I. Tsuji, and R. Nagatomi
Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 223 - 229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. Chen, W. J. Esselman, D. B. Jump, and J. V. Busik
Anti-inflammatory Effect of Docosahexaenoic Acid on Cytokine-Induced Adhesion Molecule Expression in Human Retinal Vascular Endothelial Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4342 - 4347.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Gauster, G. Rechberger, A. Sovic, G. Horl, E. Steyrer, W. Sattler, and S. Frank
Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine
J. Lipid Res., July 1, 2005; 46(7): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. J. Barter, S. Nicholls, K.-A. Rye, G.M. Anantharamaiah, M. Navab, and A. M. Fogelman
Antiinflammatory Properties of HDL
Circ. Res., October 15, 2004; 95(8): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Mishra, A. Chaudhary, and S. Sethi
Oxidized Omega-3 Fatty Acids Inhibit NF-{kappa}B Activation Via a PPAR{alpha}-Dependent Pathway
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Lopez-Garcia, M. B. Schulze, J. E. Manson, J. B. Meigs, C. M. Albert, N. Rifai, W. C. Willett, and F. B. Hu
Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women
J. Nutr., July 1, 2004; 134(7): 1806 - 1811.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Nohe, T. Johannes, H.-J. Dieterich, K. Mayer, M. Merfels, F. Grimminger, and W. Seeger
Antiinflammatory effects of {omega}-3 fatty acids vary at different stages of inflammation
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2248 - H2250.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Ziouzenkova, S. Perrey, L. Asatryan, J. Hwang, K. L. MacNaul, D. E. Moller, D. J. Rader, A. Sevanian, R. Zechner, G. Hoefler, et al.
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase
PNAS, March 4, 2003; 100(5): 2730 - 2735.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. He, E. B. Rimm, A. Merchant, B. A. Rosner, M. J. Stampfer, W. C. Willett, and A. Ascherio
Fish Consumption and Risk of Stroke in Men
JAMA, December 25, 2002; 288(24): 3130 - 3136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Toborek, Y. W. Lee, R. Garrido, S. Kaiser, and B. Hennig
Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells
Am. J. Clinical Nutrition, January 1, 2002; 75(1): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Y Abeywardena and R. J Head
Longchain n-3 polyunsaturated fatty acids and blood vessel function
Cardiovasc Res, December 1, 2001; 52(3): 361 - 371.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Tedgui and Z. Mallat
Anti-Inflammatory Mechanisms in the Vascular Wall
Circ. Res., May 11, 2001; 88(9): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Brown and F. B Hu
Dietary modulation of endothelial function: implications for cardiovascular disease
Am. J. Clinical Nutrition, April 1, 2001; 73(4): 673 - 686.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. W. Baker, K.-A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter
Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression
J. Lipid Res., August 1, 2000; 41(8): 1261 - 1267.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, J. K Liao, and P. Libby
Fatty acid modulation of endothelial activation
Am. J. Clinical Nutrition, January 1, 2000; 71(1): 213S - 223S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Kerkhoff, M. Klempt, V. Kaever, and C. Sorg
The Two Calcium-binding Proteins, S100A8 and S100A9, Are Involved in the Metabolism of Arachidonic acid in Human Neutrophils
J. Biol. Chem., November 12, 1999; 274(46): 32672 - 32679.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.